Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lloyds Banking Group Plc American Depositary Shares (LYG) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Lloyds Banking Group Plc American Depositary SharesTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Lloyds Banking Group Plc American Depositary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.65 (market cap $79.61B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 45.2× Vir Biotechnology Inc. Common Stock's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 3.99% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 3 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

LYGVIR
Market Cap
$79.61B$1.76B
Volume
13,734,6542,764,948
Sector
FinancialsHealth
52-Week High
$6.28$11.78
52-Week Low
$4.44$5.12
Typical Hold Time
3 Days0 Days
Enterprise Value
$102.02B$1.32B
Dividend Yield
3.99%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lloyds Banking Group Plc American Depositary Shares

Lloyds Banking Group (LYG) trades at $5.50, up 0.73% on the day, with a bearish technical signal from moving averages. The company reported strong profitability with a net income margin of 24.5% and has beaten earnings estimates in two of the last three quarters. Recent news highlights its 2030 growth plan emphasizing AI and efficiency, with potential acquisition interest in Aldermore.

The outlook is mixed: analyst consensus is bullish (58% buy ratings), but technicals and a recent earnings miss pose near-term risks. Upside catalysts include strategic investments and resilient UK consumers, while risks involve economic sensitivity and competitive pressures. The stock's valuation appears reasonable with a P/E of 12.98.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LYG

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Lloyds Banking Group Plc American Depositary Shares

Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.

Read more on LYG →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →